PCFFS
TAK icon

Pacific Center for Financial Services’s Takeda Pharmaceutical TAK Stock Holding History

Pacific Center for Financial Services’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15
Closed – – 340
2020
Q3 		$0 Hold
15
– – ﹤0.01% 319
2020
Q2 		$0 Hold
15
– – ﹤0.01% 317
2020
Q1 		$0 Hold
15
– – ﹤0.01% 313
2019
Q4 		$0 Hold
15
– – ﹤0.01% 325
2019
Q3 		$0 Hold
15
– – ﹤0.01% 336
2019
Q2 		$0 Hold
15
– – ﹤0.01% 332
2019
Q1 		$0 Buy
+15
New +$302 ﹤0.01% 338

Other funds holding TAK

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Pacific Center for Financial Services's TAK Position: Q4 2020 in Review

Pacific Center for Financial Services sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 15 shares.

Pacific Center for Financial Services first reported a position in TAK in Q1 2019 and held it in 7 quarters. The position peaked at $0 in Q3 2020. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

  • Pacific Center for Financial Services reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Pacific Center for Financial Services sold 15 Takeda Pharmaceutical shares in Q4 2020.
  • Pacific Center for Financial Services first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 7 quarters.
  • Pacific Center for Financial Services's Takeda Pharmaceutical position peaked at $0 in Q3 2020.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on Pacific Center for Financial Services's 13F filing for Q4 2020, filed 18 Feb 2021.